Target
Somatostatin receptor type 3
Ligand
BDBM50400525
Substrate
n/a
Meas. Tech.
ChEMBL_879796 (CHEMBL2210524)
IC50
0.500000±n/a nM
Citation
 He, SYe, ZTruong, QShah, SDu, WGuo, LDobbelaar, PHLai, ZLiu, JJian, TQi, HBakshi, RKHong, QDellureficio, JPasternak, AFeng, ZdeJesus, RYang, LReibarkh, MBradley, SAHolmes, MABall, RGRuck, RTHuffman, MAWong, FSamuel, KReddy, VBMitelman, STong, SXChicchi, GGTsao, KLTrusca, DWu, MShao, QTrujillo, MEEiermann, GJLi, CZhang, BBHoward, ADZhou, YPNargund, RPHagmann, WK The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 Diabetes. ACS Med Chem Lett 3:484-489 (2012) [PubMed]  Article 
Target
Name:
Somatostatin receptor type 3
Synonyms:
SOMATOSTATIN SST3 | SS3R | SSR-28 | SSR3_MOUSE | Smstr3 | Somatostatin receptor | Somatostatin receptor 3 | Somatostatin receptor type 3 | Sstr3
Type:
Enzyme Catalytic Domain
Mol. Mass.:
47225.49
Organism:
MOUSE
Description:
SOMATOSTATIN SST3 SSTR3 MOUSE::P30935
Residue:
428
Sequence:
MATVTYPSSEPTTLDPGNASSTWPLDTTLGNTSAGASLTGLAVSGILISLVYLVVCVVGLLGNSLVIYVVLRHTSSPSVTSVYILNLALADELFMLGLPFLAAQNALSYWPFGSLMCRLVMAVDGINQFTSIFCLTVMSVDRYLAVVHPTRSARWRTAPVARTVSAAVWVASAVVVLPVVVFSGVPRGMSTCHMQWPEPAAAWRTAFIIYTAALGFFGPLLVICLCYLLIVVKVRSTTRRVRAPSCQWVQAPACQRRRRSERRVTRMVVAVVALFVLCWMPFYLLNIVNVVCPLPEEPAFFGLYFLVVALPYANSCANPILYGFLSYRFKQGFRRILLRPSRRIRSQEPGSGPPEKTEEEEDEEEEERREEEERRMQRGQEMNGRLSQIAQAGTSGQQPRPCTGTAKEQQLLPQEATAGDKASTLSHL
  
Inhibitor
Name:
BDBM50400525
Synonyms:
CHEMBL2204938
Type:
Small organic molecule
Emp. Form.:
C27H23FN8O
Mol. Mass.:
494.5229
SMILES:
Cc1nc(no1)[C@@]1(N[C@@H](Cc2c1[nH]c1ccccc21)c1nc(c[nH]1)-c1ccc(F)cc1)c1cnn(C)c1 |r|
Structure:
Search PDB for entries with ligand similarity: